Lexpos News

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 12 July 2023) has been published and includes articles on: Hyoscine hydrobromide patches (Scopoderm 1.5mg Patch or Scopoderm TTS Patch): risk of anticholinergic side effects, including hyperthermia. Codeine linctus: public consultation on the proposal to reclassify to a prescription-only medicine. [...]

The post MHRA Drug Safety Update July 2023 appeared first on Community Pharmacy England.

PAGB, the consumer health care association, has released a report on the economic value of the over-the-counter sector. The report suggests that encouraging people to take a more a proactive approach to their health by promoting self-care could save the NHS over £1.7 billion per year by eliminating 25 million unnecessary GP appointments and five [...]

The post OTCs and self-care could save NHS £1.7bn a year appeared first on Community Pharmacy England.

The Pharmaceutical Journal Community pharmacies in England dispensed a record number of items using Serious Shortage Protocols (SSPs) in December 2022, following the publication of eight SSPs for antibiotics, data analysis by The Pharmaceutical Journal has revealed. Data from the NHS Business Services Authority showed that pharmacists dispensed 12,858 items using an SSP in December 2022, [...]

The post Record number of SSP items dispensed during penicillin shortage appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (21/07/2023) announced the following list of price concessions for July 2023: Please note CPE is still in discussion with DHSC on several other lines of concern, including other [...]

The post July 2023 Price Concessions 3rd Update appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Atomoxetine 40mg and 60mg capsules. MSN/2023/068 Tier 2 – medium impact Date of issue 21st July 2023 Atomoxetine 40mg and 60mg capsules will be out of stock from late July 2023 until September 2023 Other strengths and formulations of atomoxetine remain [...]

The post Medicine Supply Notification: Atomoxetine 40mg and 60mg capsules appeared first on Community Pharmacy England.